Ranibizumab (Lucentis)

Ranibizumab (Lucentis) is a medication used to treat eye conditions involving abnormal blood vessel growth and leakage, such as age-related macular degeneration. It is an antibody-like molecule that targets a protein called VEGF, which promotes blood vessel formation. By blocking VEGF, Ranibizumab helps reduce swelling, prevent further blood vessel growth, and improve or stabilize vision. The medication is administered through a series of eye injections by a healthcare professional. This treatment helps protect the central vision critical for activities like reading and recognizing faces.